IP Library Granted Patent US 11,052,032
Granted Patent B2
US 11,052,032 · App. 16/570,732 · Granted Jul 6, 2021

Peptide compositions and methods for ameliorating skin laxity and body contour

Inventors: Alan David Widgerow (Irvine, CA); John A. Garruto (Encinitas, CA)
Assignee: Alastin Skincare, Inc.
A61K8/64A61Q19/00A61Q19/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,052,032
App. No.
16/570,732
Granted
Jul 6, 2021
Kind
B2
Abstract

Compositions and methods for amelioration of skin laxity and body contour are provided. Provided herein are compositions comprising a combination of peptides.

Claims (21)

1. A method for improving skin laxity, texture, or crepiness, or for improving body contouring, comprising:

administering a topical composition comprising:

a tripeptide-1,

a hexapeptide-11,

a hexapeptide-12, wherein the topical composition improves skin laxity, texture, or crepiness or body contouring.

2. The method of claim 1 , wherein the topical composition is administered in conjunction with a body-shaping procedure or following a body-shaping procedure.

3. The method of claim 1 , wherein the topical composition is administered up to one day following a body-shaping procedure.

4. The method of claim 2 , wherein the body-shaping procedure comprises high frequency focused ultrasound, pulsed focus ultrasound, cryolipolysis, radiofrequency induced electroporation, injectable lipolytic agents, liposuction, a surgical body contouring procedure, or combinations thereof.

5. The method of claim 1 , wherein the topical composition is administered one, two, three, four, five, or six times a day.

6. The method of claim 1 , wherein the topical composition is administered for at least one week, 2 weeks, 4 weeks, 8 weeks, or 12 weeks.

7. The method of claim 1 , wherein the tripeptide 1 is present at 1-10 ppm.

8. The method of claim 1 , wherein further comprising a tetrapeptide.

9. The method of claim 1 , wherein the hexapeptide-11 is present at about 0.001% to about 6% by weight.

10. The method of claim 1 , wherein the hexapeptide-12 is present at about 0.5-10 ppm.

11. The method of claim 1 , wherein the topical composition further comprises one or more additional ingredients selected from the group consisting of ceramide NP, Tremella fuciformis extract, niacinamide, hydrogenated lecithin, C12-16 alcohols, palmitic acid, avocado extract, shea butter, bentonite, phytoene/phytofluene, hydroxymethoxyphenyl decanone, polyholosides, Plantago lanceolata , dill extract, phosphatidylserine, oleuropein, hydrolyzed Candida saitoana extract, Centella asiatica , propanediol, lecithin, Euglena gracilis extract, aqua, caffeine, Glaucium flavum leaf extract, or combinations thereof.

12. The method of claim 1 , wherein the hexapeptide-11 is present at about 0.002% to about 4% by weight.

13. The method of claim 1 , wherein the hexapeptide-11 is present at about 0.005% to about 0.02% by weight.

14. The method of claim 1 , wherein the topical composition is administered in conjunction with a non-invasive body-shaping procedure or following a non-invasive body-shaping procedure.

15. The method of claim 1 , wherein the topical composition is administered up to 2 days, 3 days, 4 days, 5 days, 6 days, 1 week, 2 weeks, 3 weeks, 1 month, 2 months, 3 months, 4 months, 5 months, or 6 months following a body-shaping procedure.

16. The method of claim 8 , wherein the tetrapeptide is tetrapeptide-2.

17. The method of claim 8 , wherein the tetrapeptide is present at 1-10 ppm.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2021
From: GARRUTO, JOHN A.; WIDGEROW, ALAN DAVID
To: ALASTIN SKINCARE, INC.
Reel/Frame 055219/0108 →
Continuity (5)
Division 16053674 · Aug 2, 2018
Provisional Application 62696256 · Jul 10, 2018
Provisional Application 62541036 · Aug 3, 2017
Provisional Application 62541022 · Aug 3, 2017
Related Publication 20200069550A1 · Mar 5, 2020
Cited By (1)
US 12,214,009